News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PsychoGenics Inc. Obtains an Exclusive License to the APP/PS1 Transgenic Mouse Model of Alzheimer’s Disease


8/21/2013 9:28:58 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TARRYTOWN, N.Y.--(BUSINESS WIRE)--PsychoGenics announced today that it has obtained an exclusive license from the University of South Florida to its APP/PS1 double transgenic mice (US Patent No. 5,898,094), co-expressing the M146L presenilin 1(PS1) mutation and the double mutations at K670N/M671L (Swedish mutation) in the amyloid precursor protein (APP).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES